Previous Close | 45.33 |
1-Year Change | 210.05% |
6-Months Change | 330.89% |
3-Months Change | 127.45% |
Moving Avg (50d) | 33.468 |
Moving Avg (200d) | 17.989 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 1.59B |
Beta (3-Years) | 0.82 |
Revenue Growth (ttm) | 29.07% |
Net Profit Margin (ttm) | -12.44% |
Return On Assets (ttm) | -4.97% |
EPS (ttm) | -0.45 |
PE Ratio (ttm) | -100.73 |
Dividend Yield | % |
Asset Description: | Harrow Health, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Buy |
Forecast Date: | 2024-08-08 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
44.423 | 43.064 | 42.157 | 40.797 | 38.531 | 36.264 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.